Drug Profile
Fenofibrate - AbbVie/Fournier
Alternative Names: Fulcrosupra; Lipanthyl; TriCorLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Fournier Pharma
- Class Antihyperlipidaemics; Benzophenones; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hypercholesterolaemia; Hypertriglyceridaemia
Most Recent Events
- 28 Mar 2020 Efficacy data from a clinical trial in Type 2 diabetes presented at the Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology (ACC-WCC-2020)
- 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
- 20 Nov 2012 Generic equivalent available in USA